Cellares’ CEO on building out the Cell Shuttle to automate cell therapy manufacturing
- blonca9
- Aug 30, 2023
- 1 min read
Fabian Gerlinghaus walks us through how the Cell Shuttle is designed to improve the time and cost of manufacturing cell therapies.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.